Lumida
/HQY
⌘K
Healthequity Inc

Healthequity Inc

HQY
$96.26USD+1.81%+1.71 today

MARKET CAP

8.0B

P/E (TTM)

39.1x

FWD P/E

DAY RANGE

$94 – $97

52W RANGE

$73
$108

AI Summary

Stalk
Sell NowMedium

HQY suffered a support failure in late August on high volume, confirming medium-term bearish control. Price is extended below declining 9/20/50 EMAs with rejection at resistance and RSI remains in bearish territory without reversal signals. Execution favors immediate sell-side participation while remaining alert to potential oversold relief rallies into broken support and moving averages.

  • Q2 FY27 revenue $350.7M (+8% YoY), net income $65.6M (+10%).
  • HSA accounts at 10.7M (+5% YoY); assets hit $37.9B (+14%).
  • Healthcare costs rising at near double-digit rates may dampen HSA contributions.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2022FY 2023FY 2024FY 2025FY 2026TREND
Sales, Adj.$756.6M$861.7M$999.6M$1.2B$1.3B
YoY %+3.1%+13.9%+16.0%+20.0%+9.5%
P / Sales5.9x6.0x6.6x8.2x5.8x
EV / Sales7.2x7.1x7.3x9.0x6.5x
Gross Profit, Adj.$424.8M$491.9M$622.6M$777.3M$913.1M
YoY %+2.3%+15.8%+26.6%+24.8%+17.5%
Margin %56.1%57.1%62.3%64.8%69.5%
EV / Gross Profit12.9x12.4x11.7x14.0x9.4x
EBITDA, Adj.$177.8M$198.9M$281.2M$365.3M$482.1M
YoY %-9.3%+11.9%+41.4%+29.9%+32.0%
Margin %23.5%23.1%28.1%30.4%36.7%
EV / EBITDA30.8x30.6x25.9x29.7x17.8x
EBIT$-24.2M$9.1M$117.7M$162.3M$322.5M
YoY %-171.3%+137.4%+1199.5%+37.9%+98.6%
Margin %-3.2%1.1%11.8%13.5%24.6%
EV / EBIT-225.8x671.0x62.0x66.8x26.6x
Net Income$-44.3M$-26.1M$55.7M$96.7M$215.2M
YoY %-601.3%+41.0%+313.1%+73.6%+122.5%
Net Margin-5.9%-3.0%5.6%8.1%16.4%
EPS (GAAP)-$0.53-$0.31$0.64$1.09$2.46
YoY %-541.7%+41.5%+306.5%+70.3%+125.7%